The Search for Venture Capital Continues to be Challenging
The environment for raising private capital continues to be challenging and, as a result, there has been a dramatic slowdown in the number of deals that have successfully been concluded. Worldwide, according to BioWorld Snapshots, private biotech companies developing therapeutics raised $403.5M in VC dollars in the first quarter of 2013, down a whopping 48 percent from the $775 million raised in the same period last year.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST